(Gray News) – A popular ADHD medication is being recalled nationwide because its users won’t be able to get the full effect. According to the Food and Drug Administration, several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse, are being recalled. The recall was announced Oct. 28. The Board of Pharmacy said the medication failed dissolution tests, writing, “Dissolution is important for drugs to be absorbed and have a physiological effect on the human body; they must be in solution. The impacted capsules would not be able to deliver an optimal level of medicine and may impact the therapeutic efficacy of the product.” However, officials say taking the recalled medication would not put patients at any safety or health risks. The recall affects several dosage levels of the medication, including 10mg, 20mg, 30mg, 40mg, 50mg, 60mg and 70mg pills. For a list of exact bottles and lot codes affected by the recall, click here. Sun Pharmaceutical Industries, Inc. shipped the recalled medication between May 1, 2024, and Nov. 13, 2024. The medication does not expire until 2026. Patients who have this medication are urged to contact their doctor or pharmacy for replacements or refunds.
Following shortages exist:
-
- Alvogen has lisdexamfetamine capsules available.
- Amneal has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Apotex has lisdexamfetamine capsules available.
- Hikma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Lannett has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Mallinckrodt has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Mylan (Viatris) did not provide a reason for the shortage.
- Rhodes has lisdexamfetamine capsules available.
- Solco has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Sun Pharma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
- Takeda has Vyvanse available.
- Teva did not provide a reason for the shortage.